{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T16:31:50Z","timestamp":1770913910305,"version":"3.50.1"},"reference-count":7,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Adults with Down syndrome are at high risk for Alzheimer's disease (AD), with most individuals developing clinical dementia by their late 60s. This increased risk for AD has been attributed, at least in part, to triplication and overexpression of the gene for amyloid precursor protein (APP) on chromosome 21, leading to elevated levels of amyloid \u03b2 peptides. This article offers a brief overview of our current knowledge of AD in the DS population. In addition, information on a NIA\/NICHD-funded, multicenter longitudinal study of biomarkers of AD in adults with DS is provided.<\/jats:p>","DOI":"10.1352\/1944-7558-125.2.97","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T12:44:51Z","timestamp":1581684291000},"page":"97-99","source":"Crossref","is-referenced-by-count":11,"title":["The Search for Biomarkers of Alzheimer's Disease in Down Syndrome"],"prefix":"10.1080","volume":"125","author":[{"given":"Benjamin L.","family":"Handen","sequence":"first","affiliation":[{"name":"Benjamin L. Handen, Western Psychiatric Hospital, Pittsburgh, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","reference":[{"key":"2020060221362565000_i1944-7558-125-2-97-AlzheimersAssociation1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jalz.2017.02.001","article-title":"Alzheimer's disease facts and figures","volume":"13","author":"Alzheimer's Association","year":"2017","journal-title":"Alzheimer's and Dementia"},{"key":"2020060221362565000_i1944-7558-125-2-97-Handen1","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jalz.2011.09.229","article-title":"Imaging brain amyloid in non-demented young adults with Down syndrome using PiB-PET","volume":"8","author":"Handen","year":"2012","journal-title":"Alzheimer's and Dementia"},{"key":"2020060221362565000_i1944-7558-125-2-97-Hartley1","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1093\/brain\/awu173","article-title":"Cognitive functioning in relation to the accumulation of brain \u03b2-amyloid in healthy adults with Down syndrome","volume":"137","author":"Hartley","year":"2014","journal-title":"Brain"},{"key":"2020060221362565000_i1944-7558-125-2-97-Hartley2","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neurobiolaging.2017.05.019","article-title":"Cognitive decline and brain amyloid-\u03b2 accumulation across 3 years in adults with Down syndrome","volume":"58","author":"Hartley","year":"2017","journal-title":"Neurobiology of Aging"},{"key":"2020060221362565000_i1944-7558-125-2-97-Lao1","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jalz.2015.05.013","article-title":"The effects of normal aging on amyloid-\u03b2 deposition in a population of nondemented adults with Down syndrome as imaged by [11C]PiB","volume":"12","author":"Lao","year":"2016","journal-title":"Alzheimer's and Dementia"},{"key":"2020060221362565000_i1944-7558-125-2-97-Nelson1","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1001\/archneurol.2011.104","article-title":"Positron emission tomography of brain beta-amyloid and tau levels in adults with Down syndrome","volume":"68","author":"Nelson","year":"2011","journal-title":"Archives of Neurology"},{"key":"2020060221362565000_i1944-7558-125-2-97-Wilcock1","doi-asserted-by":"crossref","DOI":"10.1186\/1742-2094-10-84","article-title":"Down's syndrome, neuroinflammation, and Alzheimer neuropathogenesis","author":"Wilcock","year":"2013","journal-title":"Journal of Neuroinflammation"}],"container-title":["American Journal on Intellectual and Developmental Disabilities"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/ajidd\/article-pdf\/125\/2\/97\/2457334\/1944-7558-125_2_97.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/ajidd\/article-pdf\/125\/2\/97\/2457334\/1944-7558-125_2_97.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T16:34:39Z","timestamp":1768322079000},"score":1,"resource":{"primary":{"URL":"https:\/\/meridian.allenpress.com\/ajidd\/article\/125\/2\/97\/432512\/The-Search-for-Biomarkers-of-Alzheimer-s-Disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,1]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3,1]]}},"URL":"https:\/\/doi.org\/10.1352\/1944-7558-125.2.97","relation":{},"ISSN":["1944-7558","1944-7515"],"issn-type":[{"value":"1944-7558","type":"electronic"},{"value":"1944-7515","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3,1]]}}}